FANJ
VRTX icon

Financial Architects (New Jersey)’s Vertex Pharmaceuticals VRTX Stock Holding History

Financial Architects (New Jersey)’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-87
Closed -$21K – 923
2020
Q1 		$21K Buy
+87
New +$20K 0.01% 506
2019
Q2 		– Sell
-137
Closed -$25K – 1483
2019
Q1 		$25K Hold
137
– – ﹤0.01% 822
2018
Q4 		$23K Sell
137
-40
-23% -$6.93K ﹤0.01% 772
2018
Q3 		$34K Sell
177
-81
-31% -$14.4K 0.01% 766
2018
Q2 		$44K Buy
258
+119
+86% +$18.4K 0.01% 602
2018
Q1 		$23K Buy
139
+21
+18% +$3.43K ﹤0.01% 850
2017
Q4 		$18K Hold
118
– – ﹤0.01% 996
2017
Q3 		$18K Sell
118
-213
-64% -$32.1K ﹤0.01% 979
2017
Q2 		$43K Sell
331
-16
-5% -$1.93K 0.01% 728
2017
Q1 		$38K Buy
347
+12
+4% +$1.06K 0.01% 741
2016
Q4 		$24K Buy
335
+99
+42% +$8.05K 0.01% 800
2016
Q3 		$21K Buy
236
+179
+314% +$16.9K 0.01% 836
2016
Q2 		$5K Buy
57
+35
+159% +$3.02K ﹤0.01% 1138
2016
Q1 		$2K Buy
+22
New +$1.99K ﹤0.01% 1083
2015
Q3 		– Sell
-129
Closed -$16K – 909
2015
Q2 		$16K Hold
129
– – 0.01% 693
2015
Q1 		$15K Hold
129
– – 0.01% 638
2014
Q4 		$15K Buy
129
+96
+291% +$10.8K 0.01% 590
2014
Q3 		$4K Buy
+33
New +$3.14K ﹤0.01% 784

Other funds holding VRTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Financial Architects (New Jersey)'s VRTX Position: Q2 2020 in Review

Financial Architects (New Jersey) sold out of Vertex Pharmaceuticals (VRTX) in Q2 2020, closing a stake of 87 shares — an estimated $21K sold.

Financial Architects (New Jersey) first reported a position in VRTX in Q3 2014 and held it in 18 quarters. The position peaked at $44K in Q2 2018. 964 funds tracked by Wall St. Rank hold VRTX as of Q2 2020.

  • Financial Architects (New Jersey) reported no remaining Vertex Pharmaceuticals position as of Q2 2020 after selling out during the quarter.
  • Financial Architects (New Jersey) sold 87 Vertex Pharmaceuticals shares in Q2 2020, an estimated $21K.
  • Financial Architects (New Jersey) first reported a position in Vertex Pharmaceuticals in Q3 2014 and held it in 18 quarters.
  • Financial Architects (New Jersey)'s Vertex Pharmaceuticals position peaked at $44K in Q2 2018.
  • 964 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2020.

Based on Financial Architects (New Jersey)'s 13F filing for Q2 2020, filed 11 Aug 2020.